Cargando…
Rapid manufacturing of non-activated potent CAR T cells
Chimaeric antigen receptor (CAR) T cells can generate durable clinical responses in B-cell haematologic malignancies. The manufacturing of these T cells typically involves their activation, followed by viral transduction and expansion ex vivo for at least 6 days. However, the activation and expansio...
Autores principales: | Ghassemi, Saba, Durgin, Joseph S., Nunez-Cruz, Selene, Patel, Jai, Leferovich, John, Pinzone, Marilia, Shen, Feng, Cummins, Katherine D., Plesa, Gabriela, Cantu, Vito Adrian, Reddy, Shantan, Bushman, Frederic D., Gill, Saar I., O’Doherty, Una, O’Connor, Roddy S., Milone, Michael C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860360/ https://www.ncbi.nlm.nih.gov/pubmed/35190680 http://dx.doi.org/10.1038/s41551-021-00842-6 |
Ejemplares similares
-
Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase
por: Durgin, Joseph S., et al.
Publicado: (2022) -
Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained
por: Pinzone, Marilia Rita, et al.
Publicado: (2018) -
CAR T-Cells Depend on the Coupling of NADH Oxidation with ATP Production
por: Garcia-Canaveras, Juan C., et al.
Publicado: (2021) -
Naive infection predicts reservoir diversity and is a formidable hurdle to HIV eradication
por: Pinzone, Marilia R., et al.
Publicado: (2021) -
Clinical use of lentiviral vectors
por: Milone, Michael C., et al.
Publicado: (2018)